SSA
GRTS

Schonfeld Strategic Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-49,200
Closed -$30.4K – 2524
2024
Q2 		$30.4K Buy
+49,200
New +$41.6K ﹤0.01% 1980
2023
Q2 		– Sell
-48,471
Closed -$135K – 2600
2023
Q1 		$135K Buy
+48,471
New +$138K ﹤0.01% 1633
2022
Q4 		– Sell
-31,200
Closed -$80K – 3101
2022
Q3 		$80K Sell
31,200
-78,600
-72% -$250K ﹤0.01% 2593
2022
Q2 		$266K Buy
+109,800
New +$288K ﹤0.01% 1734

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Schonfeld Strategic Advisors's GRTS Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 49,200 shares — an estimated $30.4K sold.

Schonfeld Strategic Advisors first reported a position in GRTS in Q2 2022 and held it in 4 quarters. The position peaked at $266K in Q2 2022. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 49,200 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $30.4K.
  • Schonfeld Strategic Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Gritstone bio, Inc. Common Stock position peaked at $266K in Q2 2022.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.